HI-TECH PHARMACAL INC
HITK
HITK was delisted on the 16th of April, 2014.
108 hedge funds and large institutions have $418M invested in HI-TECH PHARMACAL INC in 2014 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 46 increasing their positions, 25 reducing their positions, and 8 closing their positions.
88% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 8
84% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 25
7% more funds holding
Funds holding: 101 → 108 (+7)
5% more capital invested
Capital invested by funds: $397M → $418M (+$21M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
24% less call options, than puts
Call options by funds: $815K | Put options by funds: $1.08M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
+$12.3M |
| 2 |
GCIA
Gabelli & Co Investment Advisers
Rye,
New York
|
+$12.2M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$10.1M |
| 4 |
GF
Gabelli Funds
Rye,
New York
|
+$8.3M |
| 5 |
Renaissance Technologies
New York
|
+$6.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$58.9M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$2.34M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$1.1M |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
-$1.08M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$833K |
HITK Hedge Fund Activity: Q1 2014 in Review
108 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in HI-TECH PHARMACAL INC (HITK) for Q1 2014, worth a combined $418M — up 5.3% from $397M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new HITK positions and 8 closed out — a net gain of 7 holders — while 46 added to existing stakes and 25 trimmed.
The largest buyer was Glazer Capital LLC, adding an estimated $12.3M. The largest seller was Fidelity Investments, exiting entirely with an estimated $58.9M sold.
- 108 institutional investors held HI-TECH PHARMACAL INC (HITK) as of Q1 2014, up from 101 in Q4 2013.
- Funds reported $418M of HI-TECH PHARMACAL INC stock for Q1 2014, up 5.3% quarter-over-quarter.
- 15 funds opened new HI-TECH PHARMACAL INC positions in Q1 2014 and 8 closed out, a net change of +7 holders.
- The largest HI-TECH PHARMACAL INC buyer in Q1 2014 was Glazer Capital LLC, an estimated $12.3M added.
- The largest HI-TECH PHARMACAL INC seller in Q1 2014 was Fidelity Investments, an estimated $58.9M sold.
Based on aggregated 13F filings for Q1 2014.